Managed Healthcare Executive November 20, 2024
Rosanna Sutherby, Pharm.D.

Binghampton University in New York state will join Mayo Clinic and at least 15 other investigators in developing an implant aimed to treat inflammatory diseases. The project, called Engage Assess SecretE (EASE): A Platform for Treating Chronic Inflammation, is meant to act as a “living pharmacy” triggering cells to produce antibodies that could target inflammatory conditions.

The EASE project, led by Alexander Revzin, Ph.D., biochemical engineer at Mayo Clinic, is funded by a $42.8 million grant from the Advanced Research Projects Agency for Health (ARPA-H), an agency nestled under the Department of Health and Human Services and the National Institutes of Health. ARPA-H funds and supports biomedical and health research with the potential for developing high-impact and transformative treatments.

Mayo...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Health System / Hospital, Provider
Contributed Content: Everyone's Talking About Government Efficiency. Let's Apply That to Chronic Disease.
Clinical trial unearths hidden hypertension with automated searches of health records
How Intermountain Health’s cost-stewardship strategy sustains savings
OhioHealth’s plan for growth through ‘value’
Clearing The Crux: Five Paths To Achieve Health Policy Change In 2025

Share This Article